Biologics Branch (BB)
The Biologics Branch develops, produces, evaluates, or procures and distributes mammalian and insect cell cultures, cell lines, hybridomas, cell culture and microbiological media, chemical reagents, animal blood products and in vitro diagnostic products to CDC scientists for diagnostic and research purposes.
Biologics Branch personnel frequently collaborate with CDC scientists in research and development programs in the areas of gene expression, subunit vaccines, nano-biotechnology, monoclonal antibodies, mammalian cell culture and in vitro diagnostic products and reagents to meet the current needs and future demands of CDC laboratories and external partners. The branch also provides support for the production of reagents and kits to support the CDC Bioterrorism Preparedness and Response Program and influenza virus surveillance.
Biologics Branch Activities
- Provide labs with mammalian cell cultures for in vitro pathogen growth and isolation
- Provide collaborative development and production of novel monoclonal antibodies and antibody purification and conjugation
- Support laboratories with commercial and specialized media, buffers, and reagents
- Collaborate on the cloning, expression, and characterization of unique gene products
- Develop, produce, and distribute regulatory compliant reagents, reference controls, and in vitro diagnostics.
- Page last reviewed: April 8, 2011
- Page last updated: April 8, 2011
- Content source: